Who has invested in Vaxcyte?

Abingworth, Longitude Capital, Roche Venture Fund are named among the investors backing Vaxcyte.

Vaxcyte Funding: $2.4B Raised, IPO (2026)

Vaxcyte funding overview

Vaxcyte is based in South San Francisco. Vaxcyte has raised $2.4B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in February 2026. The round record for Vaxcyte runs through 2026; nothing later has been disclosed. Investors on record include Abingworth, Longitude Capital, Roche Venture Fund. 3 distinct backers are named across the disclosed rounds.

Vaxcyte at a glance

Total raised: $2.4B
Latest round: IPO
Latest round date: February 2026
Headquarters: South San Francisco
Notable investors: Abingworth, Longitude Capital, Roche Venture Fund

Frequently asked about Vaxcyte funding

How much has Vaxcyte raised?: Vaxcyte has raised $2.4B in total disclosed funding across the rounds on record.
Who has invested in Vaxcyte?: Abingworth, Longitude Capital, Roche Venture Fund are named among the investors backing Vaxcyte.
What was the latest Vaxcyte funding round?: The most recent disclosed round is an IPO, announced in February 2026.
Where is Vaxcyte based?: Vaxcyte is based in South San Francisco.
When did Vaxcyte last raise?: The last disclosed Vaxcyte round closed in February 2026 at IPO.

We update the Vaxcyte record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in South San Francisco and their backers are listed below.

Vaxcyte Funding: $2.4B Raised, IPO (2026)

Vaxcyte funding overview

Vaxcyte at a glance

Frequently asked about Vaxcyte funding

Companies related to Vaxcyte (36)

Browse related funding lists (6)